Evaluation of patients with head and neck cancer performing standard treatment in relation to body composition, resting metabolic rate, and inflammatory cytokines

Head & Neck ◽  
2014 ◽  
Vol 37 (1) ◽  
pp. 97-102 ◽  
Author(s):  
Thalyta Morandi Ridolfi de Carvalho ◽  
Daniela Miguel Marin ◽  
Conceição Aparecida da Silva ◽  
Aglécio Luiz de Souza ◽  
Maristela Talamoni ◽  
...  
Nutrition ◽  
2018 ◽  
Vol 51-52 ◽  
pp. 60-65 ◽  
Author(s):  
Micheline Tereza Pires Souza ◽  
Pierre Singer ◽  
Gislaine Aparecida Ozorio ◽  
Vitor Modesto Rosa ◽  
Maria Manuela Ferreira Alves ◽  
...  

2019 ◽  
Vol 188 (11) ◽  
pp. 2031-2039
Author(s):  
Patrick T Bradshaw ◽  
Jose P Zevallos ◽  
Kathy Wisniewski ◽  
Andrew F Olshan

Abstract Previous studies have suggested a “J-shaped” relationship between body mass index (BMI, calculated as weight (kg)/height (m)2) and survival among head and neck cancer (HNC) patients. However, BMI is a vague measure of body composition. To provide greater resolution, we used Bayesian sensitivity analysis, informed by external data, to model the relationship between predicted fat mass index (FMI, adipose tissue (kg)/height (m)2), lean mass index (LMI, lean tissue (kg)/height (m)2), and survival. We estimated posterior median hazard ratios and 95% credible intervals for the BMI-mortality relationship in a Bayesian framework using data from 1,180 adults in North Carolina with HNC diagnosed between 2002 and 2006. Risk factors were assessed by interview shortly after diagnosis and vital status through 2013 via the National Death Index. The relationship between BMI and all-cause mortality was convex, with a nadir at 28.6, with greater risk observed throughout the normal weight range. The sensitivity analysis indicated that this was consistent with opposing increases in risk with FMI (per unit increase, hazard ratio = 1.04 (1.00, 1.08)) and decreases with LMI (per unit increase, hazard ratio = 0.90 (0.85, 0.95)). Patterns were similar for HNC-specific mortality but associations were stronger. Measures of body composition, rather than BMI, should be considered in relation to mortality risk.


2019 ◽  
Vol 116 ◽  
pp. 98-106 ◽  
Author(s):  
Ah Ra Jung ◽  
Jong-Lyel Roh ◽  
Jae Seung Kim ◽  
Sung-Bae Kim ◽  
Seung-Ho Choi ◽  
...  

2020 ◽  
pp. bmjspcare-2020-002359
Author(s):  
Bing Zhuang ◽  
Lichuan Zhang ◽  
Yujie Wang ◽  
Yiwei Cao ◽  
Yian Shih ◽  
...  

ObjectivesTo investigate the body composition and dietary intake in the patients with head and neck cancer (HNC) during radiotherapy (RT), and explore the relationship between them.MethodsThis was a prospective, longitudinal observational study. Adult patients with HNC undergoing RT between March 2017 and August 2018 were recruited. Patients’ body compositions were evaluated by bioelectrical impedance analysis, and dietary intake was recorded by 24-hour dietary recall at three time points, including baseline (T1), mid-treatment (T2) and post-treatment (T3). Patients were divided into low, middle and high energy intake groups based on the average daily energy intake (DEI). Changes in body weight (BW), fat mass (FM), fat-free mass (FFM) and skeletal muscle mass (SMM) among these three groups were compared.ResultsFrom T1 to T3, the median loss of patients’ BW, FM, FFM and SMM was 4.60, 1.90, 2.60 and 1.50 kg, respectively. The loss of BW was more dramatic from T2 to T3 than that from T1 to T2. BW loss was mainly contributed by SMM loss from T1 to T2 and by FM loss from T2 to T3. Meanwhile, patients’ dietary intake reduced during treatment. High DEI group had a significantly attenuated loss of patients’ BW, FFM, SMM and FM compared with the low DEI group.ConclusionPatients’ BW, FM, FFM and SMM all significantly reduced, especially from T2 to T3, with decreased DEI during RT, which stresses the importance of nutrition intervention during the whole course of RT.


Head & Neck ◽  
2015 ◽  
Vol 38 (S1) ◽  
pp. E261-E267 ◽  
Author(s):  
Lucy Hynds Karnell ◽  
Steven M. Sperry ◽  
Carryn M. Anderson ◽  
Nitin A. Pagedar

2018 ◽  
Vol 37 ◽  
pp. S79
Author(s):  
M.T.P.D. Souza ◽  
G.A. Ozorio ◽  
P. Singer ◽  
V.M. Rosa ◽  
M.M.F. Alves-Almeida ◽  
...  

2021 ◽  
Vol 19 (2) ◽  
pp. 212-218
Author(s):  
L. B. Parkhomenko ◽  

Background: The use of magnetolaser and local hypoxia during radiotherapy for head and neck cancer leads to decrease in acute toxicity. Purpose: To reduce the severity of acute toxicity in patients with head and neck cancer using the developed methods of prevention. Material and Methods: A prospective randomized study included 120 patients with head and neck cancer. A comparative assessment of the effectiveness of the three developed methods of prevention was carried out in comparison with traditional prevention. Results: The use of magnetolaser, local hypoxia and their combination led to decrease in the level of pro-inflammatory cytokines and increase in anti-inflammatory cytokines as compared with the control group. This corresponded to a lesser degree of acute toxicity in the main groups. Conclusions: The use of magnetolaser and/or hypoxia reduces acute toxicity, which is confirmed by changes in immunity parameters.


Sign in / Sign up

Export Citation Format

Share Document